BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29473206)

  • 21. Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.
    Okuda Y; Taura K; Yoshino K; Ikeno Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Hatano E; Tanaka S; Uemoto S
    Ann Surg; 2017 Jun; 265(6):1201-1208. PubMed ID: 27355265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
    Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
    J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mac-2-binding protein glycosylation isomer is useful to predict muscle cramps in patients with chronic liver disease.
    Miwa T; Hanai T; Sakai Y; Kochi T; Katsumura N; Shimizu M
    Medicine (Baltimore); 2022 Oct; 101(41):e31145. PubMed ID: 36254085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation.
    Uojima H; Yamasaki K; Sugiyama M; Kage M; Ishii N; Shirabe K; Hidaka H; Kusano C; Murakawa M; Asahina Y; Nishimura T; Iijima H; Sakamoto K; Ito K; Amano K; Kawaguchi T; Tamaki N; Kurosaki M; Suzuki T; Matsuura K; Taketomi A; Joshita S; Umemura T; Nishina S; Hino K; Toyoda H; Yatsuhashi H; Mizokami M
    J Gastroenterol; 2024 Apr; ():. PubMed ID: 38625546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-specific elevation of serum Mac-2 binding protein glycosylation isomer levels in patients with biliary disease.
    Takagi T; Suzuki R; Sugimoto M; Konno N; Sato Y; Irie H; Watanabe K; Nakamura J; Takasumi M; Hikichi T; Ohira H
    Mol Clin Oncol; 2019 Jan; 10(1):168-172. PubMed ID: 30655993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia.
    Ueno T; Kodama T; Noguchi Y; Saka R; Takama Y; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2018 Oct; 34(10):1065-1071. PubMed ID: 30128700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritransplant kinetics of Mac-2-binding protein glycosylation isomer levels in living donor liver transplantation: its implication of posttransplant small-for-size syndrome.
    Uchiyama H; Shirabe K; Bekki Y; Toshima T; Harimoto N; Ikegami T; Yoshizumi T
    Transl Gastroenterol Hepatol; 2019; 4():41. PubMed ID: 31231708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer.
    Hur M; Park M; Moon HW; Choe WH; Lee CH
    Ann Lab Med; 2022 Mar; 42(2):249-257. PubMed ID: 34635616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection.
    Wei B; Feng S; Chen E; Li D; Wang T; Gou Y; Yang T; Zhang D; Tao C; Tang H
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28544156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
    Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
    Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy.
    Murata A; Amano N; Sato S; Tsuzura H; Tomishima K; Sato S; Matsumoto K; Shimada Y; Iijima K; Genda T
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population.
    Pham TTT; Ho DT; Nguyen T
    World J Hepatol; 2020 May; 12(5):220-229. PubMed ID: 32547689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mac-2-Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
    Wu PS; Hsieh YC; Lee PC; Yang TC; Chen YJ; Yang YY; Huang HC; Hsu SJ; Huo TI; Lee KC; Lin HC; Hou MC
    Dig Dis; 2024; 42(2):166-177. PubMed ID: 38219719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation.
    Kimura Y; Taura K; Hai Nam N; Uemoto Y; Yoshino K; Ikeno Y; Okuda Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Anazawa T; Fukumitsu K; Ito T; Yagi S; Kamo N; Seo S; Iwaisako K; Hata K; Imai T; Uemoto S
    Liver Transpl; 2021 Feb; 27(3):403-415. PubMed ID: 32780942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection.
    Liu CH; Liu CJ; Su TH; Huang SC; Tseng TC; Wu JH; Chen PJ; Kao JH
    Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct-acting antivirals.
    Chuaypen N; Chittmittrapap S; Avihingsanon A; Siripongsakun S; Wongpiyabovorn J; Tanpowpong N; Tanaka Y; Tangkijvanich P
    Hepatol Res; 2021 May; 51(5):528-537. PubMed ID: 33615687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Mac-2 binding protein glycosylation isomer level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma.
    Ishii N; Harimoto N; Araki K; Muranushi R; Hoshino K; Hagiwara K; Gantumur D; Yamanaka T; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Shirabe K
    Hepatol Res; 2019 Dec; 49(12):1398-1405. PubMed ID: 31339606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
    Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
    World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases.
    Tamaki N; Kurosaki M; Loomba R; Izumi N
    Ann Lab Med; 2021 Jan; 41(1):16-24. PubMed ID: 32829576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection.
    Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J
    Eur Radiol; 2022 Jul; 32(7):5016-5023. PubMed ID: 35142900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.